1. Home
  2. FFA vs MLAB Comparison

FFA vs MLAB Comparison

Compare FFA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Enhanced Equity Income Fund

FFA

First Trust Enhanced Equity Income Fund

HOLD

Current Price

$23.18

Market Cap

456.9M

Sector

Finance

ML Signal

HOLD

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$102.92

Market Cap

533.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFA
MLAB
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Industrial Machinery/Components
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
456.9M
533.0M
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
FFA
MLAB
Price
$23.18
$102.92
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$94.00
AVG Volume (30 Days)
21.2K
147.9K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
0.67%
EPS Growth
N/A
436.11
EPS
N/A
1.21
Revenue
N/A
N/A
Revenue This Year
N/A
$6.07
Revenue Next Year
N/A
$5.41
P/E Ratio
N/A
$83.59
Revenue Growth
N/A
N/A
52 Week Low
$19.50
$59.63
52 Week High
$23.24
$113.99

Technical Indicators

Market Signals
Indicator
FFA
MLAB
Relative Strength Index (RSI) 66.36 55.41
Support Level $21.48 $94.01
Resistance Level $23.24 $106.49
Average True Range (ATR) 0.23 4.07
MACD 0.06 0.65
Stochastic Oscillator 94.76 73.75

Price Performance

Historical Comparison
FFA
MLAB

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: